文献速递消化内镜消化道肿瘤与早癌

环周内镜黏膜下剥离术治疗表浅食管鳞癌的临床结局:回顾性研究

Clinical outcomes of circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a retrospective study.
PubMed 文献 · Gastrointest Endosc · 2026-03-27

该多中心回顾性研究评估了100例环周表浅食管鳞癌患者接受环周内镜黏膜下剥离术的短期与长期结局。整块切除率92.0%、治愈性切除率81.0%,中位随访47.4个月,3年与5年总生存率和疾病特异性生存率均为95.6%,但狭窄发生率高达88.0%,5年累积复发率19.8%。

要点

  • 环周ESD治疗环周表浅食管鳞癌整块切除率92.0%、治愈性切除率81.0%。
  • 3年与5年总生存率和疾病特异性生存率均为95.6%,肿瘤控制可靠。
  • 狭窄发生率88.0%,预防措施可降低狭窄发生率及扩张次数。

核心结论

  • 环周ESD是环周表浅食管鳞癌的有效治疗方式,肿瘤控制可靠且预后良好,但狭窄率高且复发风险约20%不可忽视。

研究设计与样本

  • 回顾性研究,纳入2个中国中心接受环周ESD的环周表浅食管鳞癌患者100例(100处病变)。

主要发现

  • 整块切除率92.0%(95% CI 85.0-96.4),R0切除率84.0%(95% CI 75.6-90.5),治愈性切除率81.0%(95% CI 72.3-88.3)。
  • 中位病变长度5.2 cm(IQR 4.5-6.0),中位手术时间97.5分钟(IQR 70.5-138.3)。
  • 不良事件包括迟发出血3.0%、穿孔1.0%、狭窄88.0%。
  • 中位随访47.4个月(IQR 34.3-65.2),3年与5年OS和DSS均为95.6%(95% CI 91.4-99.9)。
  • 累积复发率从3年16.2%升至5年19.8%;预防措施使狭窄发生率80% vs 100%(P = .007),中位扩张次数3次(IQR 1-6)vs 4次(IQR 3-9.8)(P = .028),狭窄缓解率95.5%。

临床怎么用

  • 环周ESD可用于环周表浅食管鳞癌,但需重视高狭窄率并采取预防措施。
  • 术后需严格长期随访以监测约20%的复发风险。

局限性

  • 回顾性研究设计,仅纳入2个中国中心,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Circumferential endoscopic submucosal dissection (C-ESD) is increasingly used for circumferential superficial esophageal squamous cell carcinoma (C-ESCC), although outcome data remain sparse. This study aimed to evaluate the short- and long-term outcomes of C-ESD in patients with C-ESCC. METHODS: Clinical outcomes of patients with C-ESCC undergoing C-ESD at 2 Chinese centers were analyzed. Short-term outcomes included en bloc resection rate, curative resection rate, operation time, and adverse events. Long-term outcomes comprised overall survival (OS), disease-specific survival (DSS), cumulative recurrence rate (CRR), and the efficacy of stricture prevention and management. RESULTS: A final assessment was conducted in 100 patients (100 lesions). The median lesion length was 5.2 cm (IQR, 4.5-6.0). Technical success rates were as follows: en bloc resection, 92.0% (95% CI, 85.0-96.4); R0 resection, 84.0% (95% CI, 75.6-90.5); and curative resection, 81.0% (95% CI, 72.3-88.3). The median procedure duration was 97.5 minutes (IQR, 70.5-138.3). Adverse events included delayed bleeding (3.0%), perforation (1.0%), and strictures (88.0%). With a median follow-up of 47.4 months (IQR, 34.3-65.2), 3- and 5-year OS and DSS were identical at 95.6% (95% CI, 91.4-99.9). Cumulative recurrence increased from 16.2% (3 years) to 19.8% (5 years). Prophylactic measures reduced stricture incidence (80% vs 100%; P = .007) and median number of endoscopic dilation sessions, 3 (IQR, 1-6) versus 4 (IQR, 3-9.8); P = .028. Stricture resolution was achieved in 95.5% of cases. CONCLUSIONS: C-ESD is an effective treatment for C-ESCCs. Although it achieves reliable oncological control with a favorable prognosis, its value is tempered by high stricture rates and a nonnegligible recurrence risk (∼20%). To optimize patient outcomes, advancing stricture prevention and ensuring rigorous long-term management are crucial future directions.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Dai N, Guo C, Liu P, et al. Clinical outcomes of circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma: a retrospective study. Gastrointest Endosc. 2026. PMID: 41903821. doi:10.1016/j.gie.2026.03.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。